Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

IGBC Hosts the 3rd edition of Conference on Green Factories 2026 in Vadodara to Accelerate India’s Transition to Future-Ready, Net-Zero Manufacturing

The IGBC Green Factories Conference 2026 brought together government, regulators, and industry leaders to advance …

toto slot